The long-term maintenance treatment of schizophrenic out-patients with depot flupenthixol.
D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001714:Bipolar Disorder / Q000139:chemically induced; D002389:Catatonia / Q000188:drug therapy; D003863:Depression / Q000139:chemically induced; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D006933:Hyperbilirubinemia, Hereditary / Q000150:complications; D007273:Injections, Intramuscular; D008134:Long-Term Care; D008297:Male; D009440:Neurasthenia / Q000139:chemically induced; D010044:Outpatient Clinics, Hospital; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012008:Recurrence; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*; D012562:Schizophrenia, Disorganized / Q000188:drug therapy; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D013892:Thioxanthenes / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D010879:Piperazines; D013892:Thioxanthenes; D014149:Tranquilizing Agents; D005476:Fluphenazine